Comparison of short-term peripheral nerve stimulation, single-target supraorbital nerve pulsed radiofrequency, and dual-target supraorbital nerve–stellate ganglion pulsed radiofrequency for herpes zoster ophthalmicus–associated pain: a retrospective cohort study
- 1Department of Spine and Spinal Cord Surgery, Xuchang Central Hospital, Xuchang, China
- 2Graduate School, Beijing University of Chinese Medicine, Beijing, China
- 3Department of Pain Medicine, China–Japan Friendship Hospital, Beijing, China
Abstract
ObjectiveTo compare the clinical outcomes of short-term peripheral nerve stimulation (st-PNS), supraorbital nerve pulsed radiofrequency (SON-PRF), and combined supraorbital nerve and stellate ganglion pulsed radiofrequency (SON + SG-PRF) for herpes zoster ophthalmicus (HZO)-associated pain.MethodsThis retrospective study included patients with HZO-associated pain who underwent st-PNS, SON-PRF, or SON + SG-PRF between January 2023 and January 2026. The primary outcome was the longitudinal change in Numerical Rating Scale (NRS) scores over 24 weeks. Secondary outcomes included the clinical response rate, anxiety (GAD-7), depression (PHQ-9), sleep quality (PSQI), and treatment-related adverse events. The incidence of postherpetic neuralgia (PHN) was assessed as an exploratory outcome only in patients with a disease duration of ≤90 days at treatment. Longitudinal outcomes were analyzed using baseline-adjusted linear mixed-effects models, with propensity score weighting used for sensitivity analyses.ResultsA total of 269 patients were included: 84 in the st-PNS group, 96 in the SON-PRF group, and 89 in the SON + SG-PRF group. NRS scores decreased over follow-up in all three groups. In the primary and both propensity score-weighted analyses, the overall NRS trajectory was lower with st-PNS than with SON-PRF, whereas no significant difference was observed between st-PNS and SON + SG-PRF. The overall GAD-7 trajectory was lower with SON + SG-PRF than with SON-PRF, and the overall PSQI trajectory was lower with SON + SG-PRF than with either st-PNS or SON-PRF; these differences remained statistically significant in both weighted analyses. The overall trajectories of depressive symptoms did not differ significantly among the groups. Exploratory analysis did not establish a difference in PHN risk among the three groups. No serious treatment-related adverse events occurred during follow-up.ConclusionTo our knowledge, this study is the first to compare multidimensional clinical outcomes of st-PNS, SON-PRF, and SON + SG-PRF for HZO-associated pain within the same cohort. st-PNS showed a relatively consistent analgesic benefit over SON-PRF, whereas SON + SG-PRF also provided analgesia and showed potential benefits for anxiety and sleep outcomes. These findings require confirmation in prospective studies.
Related
- Demographic Factors Influencing the Need for Repeat Radiofrequency Ablation in Chronic Pain Management: A Retrospective Study
- Association of platelet-rich plasma combined with dorsal root ganglion-targeted pulsed radiofrequency with outcomes in subacute thoracic herpes zoster neuralgia: a retrospective cohort study
- Diagnostic capabilities and monitoring the effectiveness of osteoporosis therapy using radiofrequency echographic multispectrometry in comparison with dual-energy x-ray absorptiometry
- Psoas–lumbar vertebral index and short-term pain relief after pulsed radiofrequency treatment of the dorsal root ganglion in postherpetic neuralgia in Korea: a retrospective pilot study
- Endoscope-Assisted Bilateral Supraorbital Craniotomies for Reconstruction of a Traumatic Cerebrospinal Fluid Leak in a Complex Skull Base Fracture: A Case Report.
BibTeX
@article{liang2026comparison,
title = {{Comparison of short-term peripheral nerve stimulation, single-target supraorbital nerve pulsed radiofrequency, and dual-target supraorbital nerve–stellate ganglion pulsed radiofrequency for herpes zoster ophthalmicus–associated pain: a retrospective cohort study}},
author = {Chen Liang and Anxiang Liu and Anxiang Liu and Wei Wang},
journal = {Frontiers in Neuroscience},
year = {2026},
month = oct,
doi = {10.3389/fnins.2026.1976324},
url = {https://doi.org/10.3389/fnins.2026.1976324},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Comparison of short-term peripheral nerve stimulation, single-target supraorbital nerve pulsed radiofrequency, and dual-target supraorbital nerve–stellate ganglion pulsed radiofrequency for herpes zoster ophthalmicus–associated pain: a retrospective cohort study
AU - Chen Liang
AU - Anxiang Liu
AU - Anxiang Liu
AU - Wei Wang
PY - 2026
DA - 2026/10/23
JO - Frontiers in Neuroscience
DO - 10.3389/fnins.2026.1976324
UR - https://doi.org/10.3389/fnins.2026.1976324
AB - ObjectiveTo compare the clinical outcomes of short-term peripheral nerve stimulation (st-PNS), supraorbital nerve pulsed radiofrequency (SON-PRF), and combined supraorbital nerve and stellate ganglion pulsed radiofrequency (SON + SG-PRF) for herpes zoster ophthalmicus (HZO)-associated pain.MethodsThis retrospective study included patients with HZO-associated pain who underwent st-PNS, SON-PRF, or SON + SG-PRF between January 2023 and January 2026. The primary outcome was the longitudinal change in Numerical Rating Scale (NRS) scores over 24 weeks. Secondary outcomes included the clinical response rate, anxiety (GAD-7), depression (PHQ-9), sleep quality (PSQI), and treatment-related adverse events. The incidence of postherpetic neuralgia (PHN) was assessed as an exploratory outcome only in patients with a disease duration of ≤90 days at treatment. Longitudinal outcomes were analyzed using baseline-adjusted linear mixed-effects models, with propensity score weighting used for sensitivity analyses.ResultsA total of 269 patients were included: 84 in the st-PNS group, 96 in the SON-PRF group, and 89 in the SON + SG-PRF group. NRS scores decreased over follow-up in all three groups. In the primary and both propensity score-weighted analyses, the overall NRS trajectory was lower with st-PNS than with SON-PRF, whereas no significant difference was observed between st-PNS and SON + SG-PRF. The overall GAD-7 trajectory was lower with SON + SG-PRF than with SON-PRF, and the overall PSQI trajectory was lower with SON + SG-PRF than with either st-PNS or SON-PRF; these differences remained statistically significant in both weighted analyses. The overall trajectories of depressive symptoms did not differ significantly among the groups. Exploratory analysis did not establish a difference in PHN risk among the three groups. No serious treatment-related adverse events occurred during follow-up.ConclusionTo our knowledge, this study is the first to compare multidimensional clinical outcomes of st-PNS, SON-PRF, and SON + SG-PRF for HZO-associated pain within the same cohort. st-PNS showed a relatively consistent analgesic benefit over SON-PRF, whereas SON + SG-PRF also provided analgesia and showed potential benefits for anxiety and sleep outcomes. These findings require confirmation in prospective studies.
SN - 1662-453X
SN - 1662-4548
ER -